- Market Capitalization, $K 3,293,491
- Shares Outstanding, K 30,890
- Annual Sales, $ 12,730 K
- Annual Income, $ -295,160 K
- 60-Month Beta 2.16
- Price/Sales 256.35
- Price/Cash Flow N/A
- Price/Book 4.54
|Period||Period Low||Period High||Performance|
| || |
-4.41 (-3.97%)since 11/13/19
| || |
-34.39 (-24.39%)since 09/13/19
| || |
-14.24 (-11.78%)since 12/13/18
GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, along with U.S. subsidiary Greenwich Biosciences, today...
GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, along with U.S. subsidiary Greenwich Biosciences announced...
Passing of a legalization bill by a U.S. congressional committee boosted the battered marijuana ETF space lately.
According to OrganiGram (OGI), there is hugely unmet consumer demand for CBD products.
New Records and New Milestones
Haemonetics (HAE) witnesses a steady uptick in Plasma franchise, fueled by favorable price, volume and mix.
GW Pharmaceuticals, NetGear, Cisco Systems and NetApp highlighted as Zacks Bull and Bear of the Day
Investors can still hold on to CVS Health (CVS) stock, thanks to its solid prospects.
CVS Health's (CVS) Health Care Benefits segment develops Medicare program with Aetna.
Bull of the Day: GW Pharmaceuticals (GWPH)
|Gw Pharma ADR|
|Advisorshares Pure Cannabis ETF|
|Pharmaceutical Vaneck ETF|
|Nasdaq Biotechnology Ishares ETF|
|Bldrs Europe Select ADR Index Fund Invesco|
|Bldrs Developed Markets 100 ADR Index Fund Inves|